Methoxy-9-ellipticine lactate. I. Experimental study (oncostatic and immunosuppressive actions; preclinical pharmacology).
D000470:Alkaloids / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000633:toxicity; D002455:Cell Division / Q000187:drug effects; D004285:Dogs; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000633:toxicity; D007211:Indoles / Q000494:pharmacology; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010946:Plants, Medicinal; D011926:Rauwolfia
D000470:Alkaloids; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D007211:Indoles